Form 8-K - Current report:
SEC Accession No. 0000950136-07-005534
Filing Date
2007-08-10
Accepted
2007-08-10 15:29:20
Documents
2
Period of Report
2007-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K file1.htm 8-K 16409
2 PRESS RELEASE file2.htm EX-99.1 9465
  Complete submission text file 0000950136-07-005534.txt   27677
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 071045112
SIC: 2836 Biological Products, (No Diagnostic Substances)